MDT
Medtronic plcNYSEHealthcare$86.63+0.66%OpenMarket Cap: $111.22B
As of 2026-04-06
Valuation
P/E (TTM)
24.11
PEG
2.90
P/B
2.27
P/S
3.13
EV/EBITDA
14.77
DCF Value
$173.68
FCF Yield
4.9%
Div Yield
3.3%
Margins & Returns
Gross Margin
61.9%
Operating Margin
17.9%
Net Margin
13.0%
ROE
9.5%
ROA
11.8%
ROIC
6.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $9.02B | 64.9% | $1.77B | $1.14B | $0.89 | $0.71 |
| Q2 2026 | $8.96B | 60.3% | $1.69B | $1.37B | $1.07 | $0.71 |
| Q1 2026 | $8.58B | 57.7% | $1.45B | $1.04B | $0.81 | $0.71 |
| Q4 2025 | $8.93B | 64.7% | $1.44B | $1.06B | $0.82 | $0.70 |
| FY 2025 | $33.54B | 65.3% | $5.96B | $4.66B | $3.61 | $2.80 |
| Q3 2025 | $8.29B | 66.5% | $1.65B | $1.29B | $1.01 | $0.70 |
| Q2 2025 | $8.40B | 64.9% | $1.59B | $1.27B | $0.99 | $0.70 |
| Q1 2025 | $7.92B | 65.1% | $1.28B | $1.04B | $0.80 | $0.70 |
| Q4 2024 | $8.59B | 64.6% | $1.05B | $654.0M | $0.49 | $0.69 |
| FY 2024 | $32.36B | 65.3% | $5.14B | $3.68B | $2.76 | $2.76 |
| Q3 2024 | $8.09B | 65.6% | $1.48B | $1.32B | $0.99 | $0.69 |
| Q2 2024 | $7.98B | 65.4% | $1.34B | $909.0M | $0.68 | $0.69 |